Healthcare Distribution Alliance – Patients Move Us.

+ About
- Role of Distributors
- Membership
- HDA History
- Member Directory
- Staff Directory
- Industry Recognition
- Executive Committee
- Mission and Values
- Board of Directors
- Join HDA
- Councils and Committees
- Careers
- About
  
  Information regarding HDA's history, leadership, mission, values and staff.
+ Issues
- COVID-19 Response
- Reimbursement
- Pharmaceutical Traceability
- Distributor Licensure
- Importation of Prescription Medicines
- Drug Shortages
- Prescription Drug Abuse and Diversion
- Emergency Preparedness
- Taxes
- Grassroots Advocacy
- Issues
  
  HDA reviews key priority issues and advocates on behalf of its pharmaceutical distributor members for standards, public policies and business processes that ensure a safe and efficient supply chain.
+ Events
- Distribution Management Webinar Series
- PCSC Educational Seminar
- Distribution Management Conference and Expo
- Webinars
- BLC Online
- Speaker Resource Center
- Traceability Seminar
- Events
  
  HDA regularly brings members and key healthcare supply chain stakeholders together to share industry information, learn about best practices, and be introduced to new products and services.
+ News
- Press Releases
- Blog
- Testimony
- HDA in the News
  
  Press releases, public testimony executive statements and information on HDA's efforts on behalf of pharmaceutical distributors and the supply chain.
+ Resources
- Publications
- COVID-19 Response
- Health Delivered
- Professional Development
- Webinars
- PCSC
- Allied Against Opioid Abuse
- Annual Report
- Resources
  
  HDA and the HDA Research Foundation produce a variety of resources to enhance the value of the supply chain and increase industry knowledge.

COVID-19 Response

Distributors are responding to the coronavirus pandemic.

Learn More

2020 HDA BLC Online

Join us July 20–23 for HDA's new virtual B2B offering.

Learn More

Understanding Pharmaceutical Distribution

Understanding Distribution

The HDA Research Foundation released an enhanced educational course illustrating the inner workings of the pharmaceutical supply chain.

Learn More

Health Delivered

Distributors are the backbone of the U.S. healthcare industry, saving the system between $33 and $53 billion annually.

Learn More

FEATURED UPCOMING EVENTS

2020 BLC Online

July 20 to 23, 2020

Building on the strong attributes associated with the Business and Leadership Conference, the HDA BLC Online will provide an opportunity to connect with supply chain partners though a virtual setting.

MEMBER SPOTLIGHT

R&S Northeast, LLC, formerly Dixon-Shane Drug Company, has operated as a national pharmaceutical wholesaler since 1973.

Learn More

IN THE NEWS

May 20, 2020

HDA Video Showcases Distributor COVID-19 Response Efforts

March 9, 2020

HDA Statement on FDA Drug Importation Proposal

February 10, 2020

Healthcare Distribution Alliance Names Chip Davis President and Chief Executive Officer

View All News

ISSUES IN DISTRIBUTION

Pharmaceutical Traceability

HDA is now leading industry efforts to implement the 2013 Drug Supply Chain Security Act (DSCSA) that replaced a 50-state patchwork of pedigree requirements with one federal solution to trace prescription...

Prescription Drug Abuse and Diversion

HDA and our primary pharmaceutical distributor members are committed to bringing industry and government together to tackle our nation’s complex prescription drug abuse and diversion epidemic, a serious...

Importation of Prescription Medicines

HDA opposes permitting the importation into the U.S. of pharmaceuticals sold or designated for sale in foreign countries. HDA firmly believes that allowing importation increases the likelihood of counterfeit...

Taxes

HDA opposes repeal of the Last in, First Out (LIFO) accounting method and establishment of gross receipts taxes. Healthcare distribution represents a high-volume, low-profit margin business that is impacted...